Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,087 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 386
Ph III recruiting: 46
Growth YoY: +10.6%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 1,351–1,352 of 1,352 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00312988	Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy	completed	Phase 3	450	North Eastern German Society of Gynaecological OncologyOTHER	1	Apr 11, 2006	clinicaltrials
NCT00231075	Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV	completed	Phase 2	75	ARCAGY/ GINECO GROUPOTHER	1	Nov 3, 2005